• Login
    View Item 
    •   UoN Digital Repository Home
    • Journal Articles
    • College of Health Sciences (CHS)
    • View Item
    •   UoN Digital Repository Home
    • Journal Articles
    • College of Health Sciences (CHS)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India

    Thumbnail
    View/Open
    Abstract.pdf (8.217Kb)
    Date
    2002
    Author
    Acharya, KS
    Batra, Y
    Saraya, A
    Hazari, S
    Dixit, R
    Kaur, K
    Bhatkal, B
    Ojha, B
    Panda, SK
    Type
    Article
    Language
    en
    Metadata
    Show full item record

    Abstract
    BACKGROUND: Hepatitis A virus (HAV) vaccination is recommended worldwide for patients with chronic liver disease to prevent decompensation due to superinfection with HAV. India being endemic for HAV, the prevalence of pre-existing antibodies against HAV due to subclinical exposure to the virus in childhood among patients with chronic liver disease may be high and, therefore, vaccination may not be needed. However, data are lacking on the prevalence of HAV antibody among patients with chronic liver disease in India. METHODS: Two hundred fifty-four patients attending the Liver Clinic at the All India Institute of Medical Sciences, New Delhi during the past 5 years and diagnosed to have either chronic hepatitis due to the hepatitis B virus (n = 76), hepatitis C virus (n = 84) or cirrhosis of the liver due to the hepatitis B (n = 47) or C (n = 47) virus were tested for the presence of IgG anti-HAV antibody in their sera (using a commercial ELISA kit). RESULTS: Two hundred forty-eight (97.6%) patients tested positive for IgG anti-HAV. The prevalence of anti-HAV positivity was similar among patients with chronic hepatitis B (74, 97.4%), chronic hepatitis C (82, 97.6%), cirrhosis of the liver due to the hepatitis B (46, 97.8%) and hepatitis C (46, 97.8%) virus. CONCLUSION: Vaccination against HAV is not required among patients with chronic liver disease in India as there is a very high prevalence of pre-existing antibodies in these patients.
    URI
    http://profiles.uonbi.ac.ke/sacharya/publications/acharya-sk-batra-y-saraya-hazari-s-dixit-r-kaur-k-bhatkal-b-ojha-b-panda-skvac
    http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/44990
    Citation
    KIRTDA, DRACHARYAS. 2002. Acharya SK, Batra Y, Saraya A, Hazari S, Dixit R, Kaur K, Bhatkal B, Ojha B, Panda SK.Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India.Natl Med J India. 2002 Sep-Oct;15(5):267-8..
    Publisher
    Department of Medicine, College of Health Sciences, University of Nairobi
    Collections
    • College of Health Sciences (CHS) [9822]

    Copyright © 2019 
    University of Nairobi Library
    | UoN Quality Policy | Send Feedback
     

    Browse

    All of UoN Digital RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Copyright © 2019 
    University of Nairobi Library
    | UoN Quality Policy | Send Feedback